Specialized Drugs/Medications

Viking Therapeutics’ inventory greater than doubles as traders cheer low cost entry to weight-loss-drug craze

Moderna posts shock quarterly revenue at the same time as COVID gross sales proceed to slip

AbbVie lowers first-quarter steerage after closing acquisition ImmunoGen

J&J, Merck and Bristol Myers CEOs, below fireplace on Capitol Hill, search to show up warmth on drug-market middlemen 

Novartis to bolster its oncology portfolio with acquisition of MorphoSys

Novo Nordisk’s controlling shareholder to purchase Catalent for $16.5 billion

GSK to purchase bronchial asthma drug developer for as much as $1.4 billion in pipeline push

The greatest diets of 2024 have 4 issues in widespread

Cancer-treatment developer CG Oncology information for IPO

Moderna’s inventory soars after Oppenheimer upgrades to purchase